RLT-Connect joins forces with Industry Leader to Fuel Cancer Treatment Donations
Oncidium Foundation and Telix Pharmaceuticals Collaborate to Enhance Access [...]
Will you be our new Communications Associate?
Communications Associate for a foundation in Belgium If you [...]
A great EANM23’s edition
Thank you EANM for the great edition 2023! And [...]
Oncidium Launches Global ‘RLT-Connect’ Platform
The Oncidium foundation is launching 'RLT-Connect', a revolutionary platform [...]
February 2023 – The Third Edition of Radiotheranostics Today is out!
February 4th is World Cancer Day! Access for all in [...]
Thank you for your support!
Your support and contributions at the heart of the fight [...]
Doctor, will radiotheranostics make me radioactive?
You’ve been asking for it, and we did it! The [...]
The Michael Hofman Masterclass
Event: The Michael Hofman Masterclass: PSMA - A new era [...]
EANM response to ASTRO’s framework for trainees
Letter to Editor for “European Association of Nuclear Medicine (EANM) [...]
A major component to successfully establish radioligand therapy
Tackling the Last Mile: A major component to successfully establish [...]